$0.5122
-0.05-9.18%
At close: -
$0.3699
-0.14-27.78%
After Hours: May 2, 7:59 PM EDT
Comments
Loading...
TransCode Therapeutics Stock Short Interest Report | NASDAQ:RNAZ | Benzinga
Short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) decreased during the last reporting period, falling from 2.55M to 1.04M. This put 4.45% of the company's publicly available shares short.
Short interest in TransCode Therapeutics Corp (XNAS:RNAZ) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 2.66M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
1.04M
Short Interest %
4.45%
Days to Cover
1
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics, Inc. C | 04/15/2025 | 04/25/2025 | 4.45% | 23,341,288 | 1,039,059 | 2,663,820 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/31/2025 | 04/09/2025 | — | 696,201 | 2,554,265 | 25,899,414 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/14/2025 | 03/25/2025 | 48.80% | 696,201 | 339,770 | 4,084,672 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/28/2025 | 03/11/2025 | 77.70% | 696,201 | 540,931 | 497,170 | 1.09 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/14/2025 | 02/26/2025 | 23.39% | 696,201 | 162,852 | 3,210,769 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2025 | 02/11/2025 | 52.90% | 696,201 | 368,311 | 5,919,685 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/15/2025 | 01/27/2025 | 11.62% | 696,201 | 80,907 | 122,346 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/31/2024 | 01/10/2025 | 12.87% | 696,201 | 89,617 | 151,609 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/13/2024 | 12/24/2024 | 7.53% | 696,201 | 52,411 | 41,664 | 1.26 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/29/2024 | 12/10/2024 | 87.01% | 696,185 | 605,720 | 506,540 | 1.2 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2024 | 11/26/2024 | 1.25% | 17,264,090 | 215,516 | 441,966 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2024 | 11/11/2024 | 4.31% | 17,264,090 | 743,584 | 785,242 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/15/2024 | 10/24/2024 | 7.07% | 17,259,583 | 1,221,070 | 2,221,769 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/30/2024 | 10/09/2024 | 8.01% | 17,259,583 | 1,382,893 | 4,067,605 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/13/2024 | 09/24/2024 | 5.24% | 17,259,583 | 904,669 | 2,094,520 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/30/2024 | 09/11/2024 | 1.61% | 17,259,583 | 278,561 | 558,132 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2024 | 08/09/2024 | 9.48% | 17,259,583 | 1,635,985 | 3,100,733 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/15/2024 | 07/24/2024 | 0.14% | 17,259,583 | 24,679 | 243,038 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 2.30% | 7,259,583 | 167,182 | 204,296 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 6.18% | 7,259,583 | 448,481 | 548,613 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 15.37% | 6,615,978 | 1,016,717 | 1,543,338 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 2.63% | 6,615,978 | 173,933 | 4,193,007 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 2.45% | 6,101,978 | 149,637 | 487,873 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 0.30% | 6,101,978 | 18,555 | 431,855 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 0.69% | 5,802,275 | 39,956 | 159,852 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 16.63% | 1,050,594 | 174,746 | 372,975 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 9.71% | 1,050,594 | 101,999 | 386,632 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 21.03% | 1,050,594 | 220,911 | 928,318 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 71.89% | 1,050,594 | 755,303 | 1,682,463 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 37.51% | 1,050,594 | 394,050 | 3,285,323 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 1.63% | 24,866,480 | 404,996 | 1,159,267 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 1.76% | 24,866,480 | 437,534 | 2,135,505 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/30/2023 | 12/11/2023 | 2.56% | 24,884,323 | 637,234 | 4,389,636 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2023 | 11/27/2023 | 2.43% | 19,884,323 | 483,318 | 1,832,496 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2023 | 11/09/2023 | 6.64% | 19,884,323 | 1,321,234 | 16,002,850 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/13/2023 | 10/24/2023 | 1.70% | 11,734,774 | 199,359 | 1,980,017 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/29/2023 | 10/10/2023 | 0.62% | 11,734,774 | 72,766 | 15,974,194 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/15/2023 | 09/26/2023 | 4.70% | 2,687,401 | 126,378 | 756,285 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/31/2023 | 09/12/2023 | 1.34% | 1,812,401 | 24,365 | 22,152 | 1.1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/15/2023 | 08/24/2023 | 0.10% | 1,812,401 | 1,794 | 47,587 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2023 | 08/09/2023 | 0.92% | 1,587,894 | 14,685 | 53,355 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/14/2023 | 07/25/2023 | 6.39% | 1,587,894 | 101,450 | 177,447 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/30/2023 | 07/12/2023 | 3.51% | 1,587,894 | 55,801 | 496,959 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/15/2023 | 06/27/2023 | 3.07% | 1,587,894 | 48,737 | 833,907 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2023 | 06/09/2023 | 1.09% | 2,488,505 | 27,122 | 46,932 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2023 | 05/24/2023 | 69.63% | 636,653 | 443,318 | 198,980 | 2.23 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/28/2023 | 05/09/2023 | — | 577,904 | 653,157 | 976,799 | 1 | Get Alert |
Looking for the most shorted stocks?
